This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Celgene Avilomics Research, Inc.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Margit Hagel: Innovator in HCV Protease Inhibitors
Introduction
Margit Hagel is a notable inventor based in Roslindale, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of methods for identifying HCV protease inhibitors. Her work is crucial in the fight against Hepatitis C, a virus that affects millions worldwide.
Latest Patents
Margit holds 1 patent for her invention titled "Methods for identifying HCV protease inhibitors." This patent provides innovative methods for identifying compounds that can be useful as inhibitors of the HCV protease, which is essential for the virus's replication.
Career Highlights
Margit is currently employed at Celgene Avilomics Research, Inc., where she continues her research and development efforts. Her work at this company has allowed her to focus on advancing therapeutic options for viral infections.
Collaborations
Margit has collaborated with esteemed colleagues, including Thia B St Martin and Mariana S Nacht. These partnerships have enhanced her research and contributed to the success of her projects.
Conclusion
Margit Hagel's innovative work in identifying HCV protease inhibitors showcases her dedication to advancing medical science. Her contributions are vital in the ongoing battle against Hepatitis C, and her collaborations further strengthen the impact of her research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile